drugset
drugset / Trial / NCT04250311

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 ↗

Phase 3 Suspended 314 enrolled Materia Medica Holding
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is: • to evaluate the efficacy and safety of MMH-407 in the treatment of influenza in outpatient adults.

Timeline

Start
2019-12-12
Primary completion
2024-12
Completion
2024-12

Outcome

Outcome not reported

Stopped: “Due to the end of the ARVI and influenza season, it was suspended until approximately October 01, 2023”

Drugs

EvaluationDrugModalityDoseRoute
Subject MMH-407 Unknown — Oral

Indications

influenza